Quart Barry D
SEC CIK 1384243 · EDGAR
BoughtSold
Most active insiders at KNSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sanj K | COB, CEO, Dir | — | $39.43M |
| 2 | Paolini John F. | Chief MEDICAL Off | — | $8.00M |
| 3 | Ragosa Mark | CFO | — | $5.56M |
| 4 | Tessari Eben | Chief STRATEGY Off | — | $3.10M |
| 5 | Quart Barry D | Dir | — | $2.68M |
| 6 | Megna Michael R | CAO | — | $2.64M |
| 7 | Cole G Bradley | Dir | — | $299.1K |
| 8 | Moat Ross | COO | — | $194.5K |
| 9 | McCain Tracey L | Dir | — | — |
| 10 | Levy Richard S | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 16:35 | 2026-08-19 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | G - Gift | $0.00 | -2,600 | 12.7K | -17% | $0 | |
| D | 2026-06-02 16:52 | 2026-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | — | +2,799 | 15.3K | +22% | — |
| DT | 2026-04-29 16:46 | 2026-04-28 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $14.33 | +13.1K | 25.6K | +104% | +$187.7K |
| DT | 2026-04-29 16:46 | 2026-04-28 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $50.10 | -13.1K | 12.5K | -51% | -$656.3K |
| DT | 2026-04-08 16:34 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $14.33 | +6,901 | 19.4K | +55% | +$98.9K |
| DT | 2026-04-08 16:34 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $50.00 | -6,901 | 12.5K | -35% | -$345.1K |
| DM | 2026-02-12 | 2026-02-10+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $45.00 | -2,800 | 12.5K | -18% | -$126.0K |
| DM | 2026-02-12 | 2026-02-10+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $15.47 | +2,800 | 12.7K | +28% | +$43.3K |
| DM | 2026-02-04 | 2026-02-02+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $15.47 | +16.0K | 15.1K | New | +$246.9K |
| DM | 2026-02-04 | 2026-02-02+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $45.22 | -16.0K | 12.5K | -56% | -$721.6K |
| D | 2025-12-17 | 2025-12-15 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $41.51 | -20.1K | 12.5K | -62% | -$835.6K |
| D | 2025-12-17 | 2025-12-15 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $10.36 | +20.1K | 32.7K | +160% | +$208.5K |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $3.80 | +27.4K | 20.8K | New | +$104.3K |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $30.35 | -27.4K | 12.5K | -69% | -$833.0K |
| D | 2025-06-05 | 2025-06-05 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | — | +3,173 | 12.5K | +34% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2023-07-03 | 2023-06-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | — | +5,000 | 5,000 | New | — |
| DM | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 183.2K | +12% | — |
| D | 2023-01-17 | 2022-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | J - Other | $3.27 | +1,655 | 163.4K | +1% | +$5,412 |
| D | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $3.17 | -5,219 | 178.0K | -3% | -$16.5K |
| D | 2022-12-01 | 2022-11-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | M - OptEx | $1.59 | +22.0K | 22.0K | New | +$34.9K |
| D | 2022-12-01 | 2022-11-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Dir | S - Sale+OE | $16.15 | -22.0K | 0 | -100% | -$354.6K |
| DM | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 167.0K | +13% | — |
| D | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $3.76 | -5,219 | 161.8K | -3% | -$19.6K |
| D | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $3.01 | -5,219 | 147.2K | -3% | -$15.7K |
| DM | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 152.5K | +15% | — |
| D | 2022-07-15 | 2022-04-29 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | J - Other | $3.84 | +1,504 | 132.7K | +1% | +$5,775 |
| DM | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 136.4K | +17% | — |
| D | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $6.07 | -5,219 | 131.2K | -4% | -$31.7K |
| DM | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +19.8K | 121.9K | +19% | — |
| D | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $8.30 | -5,219 | 116.6K | -4% | -$43.3K |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +3,646 | 103.0K | +4% | — |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $10.55 | -963 | 102.1K | -0.9% | -$10.2K |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | F - Tax | $13.48 | -963 | 99.4K | -1.0% | -$13.0K |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | M - OptEx | — | +3,645 | 100.4K | +4% | — |
| D | 2021-07-15 | 2021-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | CEO, Dir | J - Other | $13.90 | +1,529 | 96.7K | +2% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations